34400587|PMC8478613
{'Chemical', 'Disease', 'Species', 'Gene'}
TO THE EDITOR: Coronavirus disease 2019 (COVID-19) has had a massive impact globally. However, on June 21, the patient returned to the hospital with a reduced level of consciousness, severe anemia (hemoglobin, 3.2 g/L), and a significant drop in oxygen saturation, resulting in death on June 22.The optimal management of CLL/SLL in the setting of COVID-19 is a subject of ongoing discussions. Moreover, the impact of anti-cancer treatment on COVID-19 should be assessed.